Aktie A3EN0S ACTAVIA LIFE SCIENCES, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Actavia Life Sciences, Inc.

Aktien

A3EN0S

US7538881068

RASP

Markt geschlossen - OTC Markets
Andere Börsenplätze
 18:28:19 26.04.2024 		% 5 Tage % 1. Jan.
0,0173 USD +121,79 % Intraday Chart für Actavia Life Sciences, Inc. -.--% +124,68 %
16.02. Actavia Life Sciences, Inc. meldet Ergebnis für das erste Quartal bis zum 31. Dezember 2023 CI
05.01. Actavia Life Sciences, Inc. meldet Ergebnis für das am 30. September 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Actavia Life Sciences : Change in Certifying Accountants - Form 8-K
Actavia Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023
Actavia Life Sciences, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023
Rasna Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023
Rasna Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Rasna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022
RASNA THERAPEUTICS INC. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Rasna Therapeutics, Inc. Reports Earnings Results for the Full Year Ended September 30, 2022
Rasna Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
Rasna Therapeutics : Certificate of Incorporation/Bylaws - Form 8-K
RASNA THERAPEUTICS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
RASNA THERAPEUTICS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Rasna Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Rasna Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Rasna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021
Rasna Therapeutics : Amendment to Annual Report (Form 10-K/A)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3EN0S Aktie
  4. Nachrichten Actavia Life Sciences, Inc.
  5. Andere Sprachen